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Abstract: The coronavirus disease 2019 (COVID-19) pandemic is affecting society’s health, economy,
environment and development. COVID-19 has claimed many lives across the globe and severely
impacted the livelihood of a considerable section of the world’s population. We are still in the process
of finding optimal and effective solutions to control the pandemic and minimise its negative im-
pacts. In the process of developing effective strategies to combat COVID-19, different countries have
adapted diverse policies, strategies and activities and yet there are no universal or comprehensive
solutions to the problem. In this context, this paper brings out a conceptual model of multistake-
holder participation governance as an effective model to fight against COVID-19. Accordingly,
the current study conducted a scientific review by examining multi-stakeholder disaster response
strategies, particularly in relation to COVID-19. The study then presents a conceptual framework for
multistakeholder participation governance as one of the effective models to fight against COVID-19.
Subsequently, the article offers strategies for rebuilding the economy and healthcare system through
multi-stakeholder participation, and gives policy directions/decisions based on evidence to save
lives and protect livelihoods. The current study also provides evidence about multidimensional
approaches and multi-diplomatic mechanisms during the COVID-19 crisis, in order to examine
dimensions of multi-stakeholder participation in disaster management and to document innovative,
collaborative strategic directions across the globe. The current research findings highlight the need
for global collaboration by working together to put an end to this pandemic situation through the
application of a Multi-Stakeholder Spatial Decision Support System (MS-SDSS).
Keywords: COVID-19; multistakeholder participation; networking/collaboration; spatial decision
support system; disaster management
1. Introduction
The world is facing the coronavirus disease 2019 (COVID-19) pandemic, which is
having an unprecedent effect on people’s lives and livelihoods, leading to severe and
long-term impacts at individual, community and societal levels. The pandemic crisis
involves not only health issues but also economic issues [1]. Pandemics are not new to
human society; however, their nature, intensity and the way societies respond change
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over time. In history, we have seen the most devastating pandemic, called the “black
death”, which shook the world from the years 1347 to 1352 and took the lives of more
than 75,000,000 people [2]. In the years 1918 to 1920, there was another pandemic called
the “Spanish Flu”, where more than 100,000,000 people died [3]. Pandemics create un-
certainty, complexity in understanding and there is need for new knowledge. In order
to access new knowledge, it is important that we integrate the best available knowledge
and reconcile often conflicting values and viewpoints. There is a need to find solutions to
dealing with complicated, wicked problems such as COVID-19 that will involve complex
interactions between technological, social, environmental, behavioural, managerial and
medical worlds; one such strategy is multi-stakeholder participation [4], and we propose
this can be combined with Multi-stakeholder Spatial Decision Support systems (MS-SDSS).
The aim is to help the world to be prepared for future problems and challenges that include
pandemics [5].
As the impact of the COVID-19 pandemic is multidimensional, affecting all spheres
of life and across the global population, no single agency or stakeholder can work alone
to control COVID-19 effectively and mitigate its impact. In order to better respond to
and manage the COVID-19 situation, we need to deploy appropriate multi-stakeholder
management strategies which can improve the effectiveness and efficiency of crisis and
humanitarian operations [6]. It is important that competencies are developed at all levels
for emergency, crisis prevention and management. COVID-19 is partly a spatial problem,
highlighting the importance of quarantine, segregation and isolation in homes, workplaces
and cities [7,8]. Controlling and managing these spatial issues requires an integrated,
scientific approach that can help in the aggregation of spatial and non-spatial data, quick
visualisation of epidemic information, spatial tracking of confirmed cases, estimation of
regional transmission, and provide solid spatial information support for decision-making,
measures formulation, and effective assessment of COVID-19 prevention and control
measures [9,10].
In order to fight against COVID-19, the paper presents a conceptual model for multi-
stakeholder governance which includes various stakeholders, their strategies and, in partic-
ular, a multi-stakeholder spatial decision support system. At present, there are no bespoke
models of multi-stakeholder participation for dealing with COVID-19 that combine the
advantages of a multi-stakeholder spatial decision support system. The model is developed
based on directly and indirectly relevant research articles on disaster management; this
is relevant because COVID-19 is a disaster and requires focused on multi-stakeholder
participation. The paper aims to understand the implication of COVID-19 on health and
development and specifically explore the most effective role for multi-stakeholder par-
ticipation, as part of managing the epidemic response. However, it is acknowledged
that the research only provides a snap shot of the possibilities and challenges related to
multi-stakeholder participation, as the pandemic is still ongoing globally, and various
stakeholders are altering, upgrading and/or updating their strategies. The paper presents
a conceptual model which would be a great help towards controlling the COVID-19 pan-
demic and deal with its long-term impacts most effectively, and which contributes both
theoretically and managerially to knowledge in this area. This helps agencies, governments
and other stakeholders involved in fighting against COVID-19, with an aim to inspire re-
searchers to take up empirical enquiries and policy makers to define polices and strategies
to fight the pandemic.
2. Synthesis of Literature Review
2.1. Multi-Stakeholder Participation
The role of multi-stakeholders participation in this context is to work towards policy
decision-making and action on global development issues, distribution of commitment and
responsibility among themselves, to bring about collective action solutions for public bene-
fit, establishing clear roles and responsibilities, getting involved in proactive prevention
activities and working for community governance [11]. One of the operational definitions
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of multi-stakeholder participation is that it involves participation among vested-interest
groups as a core activity. Multi-stakeholder collaboration may improve service delivery
and participation at international, national, local/regional and community levels [12].
However, multi-stakeholder participation in decision analysis tends to become quite com-
plex, and the outcomes can be both positive and negative. To minimise the negative results
and maximise the positive outcomes, a systematic, holistic approach is required, where
every stakeholder has a role to play and contribute significantly to the decision-making
process [13].
2.2. Interlinking of Multi-Stakeholder Spatial Decision Support System (MS-SDSS)
To address COVID-19, it is important to face the challenges from an interdisciplinary
approach, with proactive planning, international solidarity and a global perspective [7,14,15].
For Multi-stakeholder participation, an important issue is exploring the possibility of adop-
tion of MS-SDSS to address the challenges caused by the pandemic. The spatial decision
support system (SDSS) is a computer-based information system designed to support poli-
cymakers and practitioners in decision-making processes [16]. In this context, SDSS offers
a platform for the interaction of public health officials, affected actors, and first respon-
ders to improve estimations of disease propagation and likelihoods of new outbreaks [7].
Understanding the spatiotemporal dynamics of COVID-19 is essential for its mitigation,
as it helps to clarify the extent and impact of the pandemic and can aid decision making,
planning and community action. SDSS helps to integrate the science, data and models with
decision-making at different levels of operations, policy and governance in a sustainable
way over the long term [17]. A multi-stakeholder decision support system, containing data,
models, tools, and a design process can assist local authorities in preparing an integrated
plan for fighting COVID-19 (Figure 1); in order to facilitate multi-stakeholder planning,
a design process (Figure 1) is required [18].
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Figure 1. Conceptual design of Multi-Stakeholder Spatial Decision Support System (MS-SDSS).
In this design, the multiple stakeholders are involved in the decision-making process
from the problem structuring stage to the scanni g of alternatives to identify the fficient
one stage, followed by the last stage a set of well-studied and carefully sel cted efficient
alternatives [19].
3. Methodology
Review of Global Methodological Procedures
There are so many methodologies (explained in Sections 1 and 2) to review the litera-
ture globally, particularly in the multi-stakeholder participation in disaster management
fields. However, we selected the scientific review methodological procedures for the cur-
rent study. Accordingly, a fundamental concept of methodology has been taken from
Kantamaneni [20] and subsequently applied to the current study. The present scientific
literature review critically explores multi-stakeholder disaster response strategies more
broadly and COVID-19 MS responses more specifically. In order to carry out the scientific
literature review, first, a protocol was developed for the inclusion and exclusion crite-
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ria, then literature review and meta-analyses were identified and subsequently analysed
(Figure 2).
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The current study searches the various search engines and data sources: ADB (Asian
Development Bank), BioSci (BioScience), BMC (Biomed Central), Elsevier journals, Future,
HSB (Harvard School of Business), JAMA (Journal of the American Medical Association),
JPHP (Journal of Public Health P licy), Lancet, MDPI (M ltidisciplinary Digit l Publish-
ing Institute) journals, Nature, NIH (National Institutes of H alth) public acces , Policy
Sc. (Policy Science), PubMed (P blic/Publish r MEDLINE) papers, Sci nce Adv (Science
Advances), Springer journals, Google scholar, S stain Sci (Sustainability Scienc ), UNDP
(United Nations Development Programme) report, UN (United Nations) repor s, WHO
(World Health Organization) reports and Wiley publications (open access). The keywords
that were used to identify the relev t data/case a e: COVID-19, mu tistakeholder partici-
pation, disaster man gem nt, crisis manag ment, networking, coll borations, global health,
governanc , crisis m nagement, multidimensional h alth are, civil society organizations
and bilateral and multi-lateral organizatio s. After the search, 825 various literature sources
were identified; how ver, a review then found th t some of those were not relevant to
the current study. Accordingly, 432 sources were excluded fr m the analysis after initial
screening. Then, the remining 403 articles were scrutinised for the second screening. After
detaile and careful consideration, 220 more papers were excluded from the analysis.
Finally, 183 were considered for full analysis.
The inclusion criteria comprised of selecting, empirically peer-reviewed studies, peer-
reviewed reviews and conceptual frameworks which were related to disaster management
and COVID-19. The exclusion criteria included non-peer-reviewed papers, studies on
multi-stakeholder participation that were not related to disaster management, and COVID-
19 studies which were not published in the English language and studies not exactly related
to the current study. While analysing the literature, we found that there were a limited
number of empirical studies on multi-stakeholder participation in disaster management
that involved pandemic crisis and limited availability of data. There is further lack of
data as not all countries have data on multi-stakeholder participation and a lack of im-
pact assessment studies on multi-stakeholder participation. The research presents the
approaches, methods and strategies followed by different countries as case syntheses in
handling COVID-19 based on the available literature at the time of writing this paper. There
is a strong possibility that some countries might change their methodology and strategies
as the COVID-19 situation is still on-going. Most importantly the research lacks empirical
evidence on multi-stakeholder participation during COVID-19.
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4. Scientific Review Results
4.1. Taxonomy of COVID-19
The COVID-19 pandemic has spread world-wide very rapidly and aggressively within
a very short timeframe. Countries across the globe have adopted various prevention and
control measures to minimise negative health impacts [21]. The COVID-19 pandemic and
the associated economic and social crisis are posing huge challenges, including, but not
limited to, availability of accurate information, free/affordable COVID-19 testing and
treatment emerging issues related to jobs and income of millions of people, lack of social
safety-net programs, lack of income support schemes, increased burden on women to
manage family problems and the plight of migrants and informal sector workers, which
are some of the important effects of this pandemic on human lives [22]. Other serious chal-
lenges relate to the restriction on economic activities, commercial, services and industrial
production, the inability of firms to sell their goods and services, leading to high economic
and social costs around the world due to social distancing, lockdown and quarantine [23].
More than 30 million people could fall into poverty in the absence of active policies to
protect or substitute income flow to vulnerable populations [24].
The major societal impacts of COVID-19 include health inequality [25,26], social
stratification [27], low-income individuals disproportionally affected [28] and lack of access
to essential healthcare services [29]. There are gender issues like the dual burden on work,
limitations of working from home and an increase in domestic violence and violation of
human rights. There are increases in individual isolation, which may result in a reduction
of human happiness and mental wellbeing, potentially leading to rises in psychological
issues including suicide, grief, survival, and fear [24]. There are major effects on the
economy including the informal sector [30], fear of losing one’s job [31], pay cuts [23],
pending time-bound project completion [32], lack of interpersonal relationships [33] and
lack of data/adequate information [34,35]. There are impacts on socio-environmental
issues including living conditions and mass gatherings. There are impacts on persons
with special needs including elderly issues, absence of social security measures and lack
of access to essential services. COVID-19 affects religious practices, particularly from the
closure of places of worship and cancellation of religious services [36].
4.2. Emerging Trends in Multi-Stakeholder Participation
The literature review highlights emerging trends in multi-stakeholder participation
including global preparedness/contingency planning, the lack of post-crisis reconstruction
and recovery, the presence of weak legal and institutional mechanisms, weak infrastruc-
tural facilities including communication networks, the lack of systematic and periodic
assessment, the lack of accounting of potential losses, and the presence of poorly managed
financial, technical and human resources. Other challenges include managing spontaneous
behavioural reactions e.g., generalised panic, rumours/conspiracies regarding the spread
of COVID-19, exposure to the elements (living conditions) and availability of good food
and nutrition to fight against COVID-19. Furthermore, there is a need to work for vaccina-
tion, rehabilitation, water supply, food safety, basic sanitation, personal hygiene, research
into other zoonotic diseases and investment in research and development [37].
4.3. Enhancing Nationwide Preparedness and Responses
One of the challenges involved in the process of nationwide preparedness to fight
against COVID-19 is that it can lead to a national emergency [38]. This calls for dedicated
funding for staffing, equipment and resources and resource allocations that are needed to
support state, local and other health departments. Strengthening the linkages among all lev-
els of state and non-state actors is very important to ensure multi-stakeholder participation
in handling this pandemic (Table 1) [39].
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Table 1. Case synthesis of multi-stakeholder activities to control COVID-19.
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emergency response, rapid response,
effective anti-COVID-19 measures,
rapid testing, effective isolation strategy,











Large scale coordination, institutional
timely response, community resilience,










Produce PPE (personal, protective
equipment), fundraising, collaboration
with healthcare service providers,
inducting additional Labs, effective
testing and contact tracing, effective













undermining the virus, triple “Ts”
(testing, tracing and treatment)
Govt, CSOs [68–73]
Turkey Lockdown, proactivepolicy style
Rapid and strong response, extensive











Well-functioning federalism, long term




Closure of non-essential public places
and services, internal and international
travel restrictions, cancellation of public
events, all covid-19 system—care
categorization and anticipation strategy
Govt, health
department [55,81–84]
Japan Emergency(sub-national and local)
Effective implementation of
self-discipline, avoiding “Three Cs”
(closed spaces with insufficient
ventilation, crowded conditions with
people, and conversations at a short
distance), no lockdown,
recommendations regarding closure of
schools and work places, public
information campaigns
Govt, community [40,55,85–88]
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recommendations on social distancing
and working online, voluntary
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Germany Social lockdown &Economic lockdown
Nation–wide social distancing and
contact restrictions, personal care
business centres were closed (hair
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gathering, social distancing, border
control, rapid and science-based risk
assessment, rapid testing and contact
tracing, community transmission
control measures, promotion of hand
washing hygiene, medical preparedness,












From the above Table 1, we can understand the approaches, methods and strategies
followed by different countries. For example, Taiwan used networking, proactive testing,
border control and transparency as a method to handle the situation. They had frequent
health check-ups, public education and relief measures to business as strategies to manage
the crisis. Using multi-layer governance, they partnered with local government, private
organisations, insurance companies and citizens to manage the COVID-19 situation [40–44].
South Korea used timely emergency response and a nationwide framework of networks of
stakeholders as a method and, as a strategy, they followed shared interest, priority-based
emergency responses and rapid response, partnering with government, community and
chief scientific officers [45–50]. China and Singapore used the collaboration of scientists
including social sciences as a method. As part of this strategy, they used large-scale
coordination as an institutional and timely response and partnered with government,
industry, banks and financial institutions and worked for community resilience [51–55].
The USA used networking as a basic method; and outbreak management and infection
control as their strategy. They partnered with multi-layer government, private industries
and companies and CSOs (Civil Society Organisation) [56–59]. Malaysia used movement
control orders as a method and followed these steps with their strategies including pro-
ducing more PPE (personal, protective and equipment), fundraising, collaboration with
healthcare service providers and inducting additional laboratories. They partnered with
government, CSOs and the community [60–63]. India used lockdown as a method and
used emergency management and interstate transmission control as strategies to manage
the situation. They partnered with multi-layer government, private sector organisations
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and CSOs [56,64–67]. Italy used pandemic management as a method and institutional
arrangements as their strategy. They partnered with government and CSOs [68–73].
Turkey used lockdown and proactive policy for their method. They used rapid
and strong response, extensive use of institutional resources and factual information
campaigns as their crisis management. They partnered with government, community and
the religious leaders [74–76]. Canada used social distancing, travel restrictions, integration
of social sciences as their method. They used well-functioning federalism, long term care,
rapid testing and tracing, face mask mandates as their crisis management; partnered with
multilayer government [77–80].
France used nationwide lockdown as their method, using closure of non-essential
public places and services, internal and international travel restrictions, cancellation of
public events, care categorization and anticipation strategy as their crisis management,
partnered with government and health department [55,81–84].
Japan used emergency (sub-national and local) as their method. They used effec-
tive implementation of self-discipline, avoiding “Three Cs” (closed spaces with insuffi-
cient ventilation, crowded conditions with people, and conversations at a short distance),
no lockdown, recommendations regarding closure of schools and work places and public
information campaigns as their crisis management. This was partnered with government
and community [40,55,85–88].
Sweden used pandemic management—long term plan as their strategy. They used
temporary bans on nonessential travel, recommendations on social distancing, working
online, voluntary self-protection, non-closure of gyms, schools, restaurants and shops as
their crisis management. This was partnered with government, voluntary organizations,
and community [55,89–93].
Germany used social lockdown & economic lockdown as their method. They used
national–wide social distancing and contact restrictions, personal care business centres were
closed (hair dressers, tattoos, massage centres, etc.), different states followed different styles
of lockdown for example strict lockdown—stay at home order and lenient lockdown—not
to leave the house without a reason, closure of churches, recommendation on wearing of
face masks, good medical preparedness, developed a reliable testing system, stock of testing
kits, early testing and tracing as their crisis management. They partnered with government
(National & Federal state), public and private hospitals, medical professionals, virologists,
public health experts, laboratories, community, self-discipline, and citizens [94–99].
New Zealand used lockdown as their method. They used lockdown measures, closure
of schools, non-essential workplaces, travel restrictions, restrictions on social gathering,
social distancing, border control, rapid and science-based risk assessment, rapid testing and
contact tracing, community transmission control measures, promotion of hand washing
hygiene, medical preparedness, arranged more ICU & ventilator facilities and safeguarding
healthcare professionals as part of their crisis management. They partnered with govern-
ment, public and private hospitals, medical professionals, virologists, public health experts,
laboratories, community, self-discipline and citizens [100–104].
It is evident that, different countries adopted various strategies to accommodate multi-
stakeholder participation to handle the pandemic and its impact on lives. The approach
to method and strategies varied upon the number of cases, available resources and the
socio-political structure of the country.
5. Policy Announcement from Selected Countries for COVID-19
National Level COVID-19 Public Health responses included international travel restric-
tions, improving health facilities, setting strict following quarantine rules, guidance and
compliance; tracking and testing, building up advisory systems, creating public awareness,
controlling non-essential businesses, strengthening government services, restrictions on
mass gathering, closure of schools and universities and imposing curfews. Some countries
implemented good health data management/epidemiological databases, declared a state
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of emergency, imposed internal travel restrictions, implemented lockdown policies and
followed decentralised communication as shown in Table 2.
Table 2. Policy announcements for COVID-19.
International travel restrictions [105,106]
Improving health facilities [107]
Strict quarantine measures [108–110]
Tracking and testing [47,108,111–113]
Built new hospitals for the treatment COVID-19 [110]
Building up advisory systems and Creating public awareness [47,114]
Stoppage of Non-essential businesses [108,112]
Strengthening Government services [115,116]
Restriction on mass gathering [108,112,116]
School and university closure [108,109,112,116]
Curfew [109,112,117]
Health data management/ epidemiological data base [47,108,114]
State of emergency [108]
Internal travel restriction [112]
Lockdown policy [111,112,117–119]
Decentralised communication [47]
community to be proactive, sharing of responsibility [120,121]
Stakeholders and clinical manifestation of COVID-19 [45,122]
While others made the community be proactive, coordinated the works with clear role
clarity, coordinated different policies, shared responsibilities and implemented effective
public health measures. Some connected with their stakeholders by establishing mutual trust
and through clinical manifestation to manage COVID-19 [40,45,47,51,56,60,68,105–117,120–132].
Strategies Followed to Combat COVID-19
Various countries followed different strategies like extensive testing, contract tracing,
community mobilisation, crisis precautions, cluster containment strategy, public health
surveillance, proactive state leadership, proper planning, knowledge of COVID-19, expect
the unexpected, creating awareness, service orientation and supply chain information to
fight against COVID-19 (Table 3).
Table 3. Case synthesis of lessons learned from the experience of different countries.
Lessons Learned from the Experience of Different Countries
1. Strengthen crisis management and response strategies [133]
2. Recognize your cognitive biases [134]
3. Avoid partial solutions [69]
4. Learning is critical [48]
5. Extensive testing of symptomatic and asymptomatic cases early on [135]
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Table 3. Cont.
Lessons Learned from the Experience of Different Countries
6. Proactive tracking of potential positives [136]
7. A strong emphasis on home diagnosis and care [137]
8. Specific efforts to monitor and protect health care and other essential workers [138]
9. Collecting and disseminating data is important [139]
10. The resilience of affected/infected individuals [140]
11. Awareness of the plight of farmers, labours [141]
12. Social protection measures [142]
13. A robust collection of health data, and epidemiological database (for health policies) [143]
14. To ensure public health surveillance [144]
15. Recognition of the role of international non-governmental organisations (INGOs) [145]
16. Timely provision of medical supplies and hygiene kit [146]
17. Provision of social support and care to the appropriate communities and vulnerable
populations [147]
18. Coordination of funding activities and volunteers [148]
19. R&D in life-saving medical innovations [149]
20. Test, Test and Test again [150]
Lessons learned from different countries involve the strengthening of crisis manage-
ment and response strategies, increasing efforts to recognise cognitive bias and avoid
partial solutions. Learning is critical and a readiness to accept the limitations is necessary.
Understanding that extensive testing of symptomatic and asymptomatic cases early and
proactive tracing of potential positives is very important. A strong emphasis on home
diagnosis and care, specific efforts to monitor and protect health care and other essential
workers, and collecting and disseminating data are important, as well as the resilience of af-
fected/infected individuals [151]. It is important to address the plight of farmers, labourers
and workers towards social protection measures. Health departments should concentrate
on the robust collection of health data and epidemiological databases (for health policies
and to ensure public health surveillance). The government should recognise the role of
local international non-governmental organisations (INGOs) to the pandemic response and
encourage timely provision of medical supplies and hygiene kit to individuals. The govern-
ment should focus on the provision of social support and care to appropriate communities
and vulnerable populations, co-ordination of funding activities and volunteers, R&D in
life-saving medical innovations and to Test, Test and Test again the people in order to bring
COVID-19 under control [40,45,48,51,56,60,68,69,123–130,133–151].
6. Discussion
The paper has presented different strategies, policies and methods used by different
countries to fight against COVID-19. There is no one solution that can solve COVID-19,
but through multi-stakeholder participation it is possible to find the most appropriate
strategies to fight against COVID-19. Countries need to identify innovative and cultur-
ally acceptable measures to combat this crisis. Efforts should be taken to identify easily
available, culturally adaptable local technology that is accessible and affordable to every-
one. There is a need to address the immediate and long-term impacts of COVID-19 [152].
In pandemic times, there must be promotion of culturally acceptable strategies for phys-
ical distancing coupled with social solidarity [153]. There is a need to advocate for the
advancement and strengthening of social welfare services as an essential protection against
the pandemic [154]. There is a need to develop capabilities at all levels for emergency
and pandemic prevention and management where each stakeholder’s strength and skills
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are identified, targeted and harmonised within general response and management sys-
tems [155].
There is a need to strengthen inter-organisational coordination, participation, ac-
countability and local responsibility with central coordination to handle the pandemic
impact effectively [156]. Societies also need significant resources and dedicated funding to
deal with emerging and re-emerging infectious diseases focusing on its future recurring
possibilities, prevention and management [157]. There should be incentives given to peo-
ple for early reporting [158] followed by developing strategies to prevent antimicrobial
resistance [159,160].
The health impact of recent outbreaks should be properly studied and there is a need to
communicate effectively with public health emergency management including hazard and
risk assessment, prevention and mitigation, incident management, resource management,
communications, operations and training, exercising evaluation, corrective action and
quality improvement [161]. Government should focus on the impact of sudden job losses
and depletion of income due to COVID-19 and acute hardships for millions of urban
and rural households, especially those working in the informal sector with no contracts,
including migrants. Governments should find solutions to the complex challenges of health
and nutrition, poverty, hunger and acute undernourishment of several million people,
rising domestic conflict, violence and depression. Major economic problems like a reversal
in capital follow as global risk, oil market deep-diving into negative, economic stagnation
and the plight of labour, require further attention. Governments must also address the risk
of health inequalities especially in vulnerable groups [162–164].
Importance and Implications of Public Policies
While communicating to people there should be credible communication to the public
without politicising the message [165]. Countries should come together, even if digi-
tally/virtually, in order to take bold action since the virus knows no borders [166]. The pub-
lic sector must lead society with a global approach to mitigate the impact of COVID-19.
This involves public health emergency actions, identifying economic impacts, and com-
bating misinformation and disinformation about the disease and its spread (Harvey, M.
Whole of Society Approach [167]). Governments should focus on providing authoritative
information via multiple sources to ensure accurate data, to slow the spread so that our
health systems are not over-stressed (Kayyem, J. Disruption is the Plan [167]). There is
a need to encourage increasing transparency, impose control measures and appropriate
restrictions, design suitable prioritisation guidelines regarding the allocation of scarce
resources and make use of effective technologies (Saghafian, S. Transparency, Control,
Prioritization [167]). Countries should strive to recognise the potential for psychological
burnout from long hours of work and potential demoralisation from persistent stress
(Howitt, A.; Leonard, H. Energetic Mobilization [167]). Governments need to strike a
balance between protecting the health of people and respecting human rights (Sikkink, K.
Rights and Responsibilities [167]); to invest in vaccine and therapeutics against COVID-19
(Chandra, A. Vaccine Investment [167]); and to identify new priorities and revisit national
spending priorities (Bilmes, L.J. How the Public Sector and Civil Society Can Respond to
the Coronavirus Pandemic: New Priorities [167]). The government should address the
long-standing challenges of health and nutrition of low-income households [168]. Govern-
ments must create synergy between partners and encourage collaboration to identify and
engage in strong partnerships.
7. Suggestions for Effective Interventions
Despite the breadth of this study, we are not presenting generalised suggestions for
the most effective interventions, as there is so much variation across contexts, cultures and
climates, and no single approach is most appropriate in all cases. Instead, we present the
multi-stakeholder participation model as one of the appropriate models to be implemented
in combating COVID-19. We need to create effective mechanisms through which to enable
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collaboration between international, national and regional organisations, and we should
strive to establish pathways through which multiple actors can work together [169] and
create synergy among society, economy and development [170]. An understanding of
pandemic risks in all its dimensions, interlinking of disaster management and development
planning is required [171]. There is also a need to encourage clinical and community-based
research [172] and to strive to enhance healthcare data management for evidence-based
research [173,174]. Successful interventions always assess the felt need of the community
and then, through active and effective legal enforcement as required, facilitate and enable
education to create a context of personal and public accountability and social responsibility.
Self-discipline is one of the better interventions through which we can fight against COVID-
19 so this can be achieved successfully [40]. The most effective intervention may be a
combination of the different suggestions presented according to the needs, wants and
situation of each country.
Scope for Future Research
There is a need to better understand the COVID-19 crisis life cycle [175], and more
research is required to know the causes and consequences (recovery, mitigation, response
and preparation). Further analysis can be done by revisiting datasets, redefining relevant
methodologies, facilitating access to online resources and exploring culturally relevant
approaches. There is a need to improve access to relevant information sources and compile
robust data of active and closed COVID-19 cases and their relatives. We need to evolve a
global monitoring framework and find ways to implement the sustainable development
goals [176]. Additional work is required to explore COVID-19’s impact on social develop-
ment, human happiness and well-being of professionals, carers, their families and others in
the community. Evidence must be synthesised more rapidly and it is needed the provision
of large-scale intervention guidelines and longer-term strategies for human happiness, well-
being, social and economic recovery. Further work is required to ensure adequate quality of
research work and to better communicate the findings with multi-stakeholders, including
policy briefs. There is a need to strengthen community-based crisis risk management,
replicate best practices and learn from the field of diverse multispectral partnerships [177].
8. Limitations
Although the present study has accomplished some significant and interesting results,
there are certain research limitations and challenges that can be improvised for better
research in this field. First, due to the lack of available consistent data on global pandemic
COVID-19 multi-stakeholder participation in diverse aspects, it took a lot of time to collect
and finalise the data sets. Second, significant differences in various technical subjects
(e.g., SDSS) led to challenges in identifying the real current situations. Third, due to the
lockdown, work restrictions and lack of full physical access to the universities, some
library facilities were not available for the data search. This is to be a major limitation
and could be better addressed in future research. Finally, during the data collection, some
organisations, particularly for government organisations, did not respond within the time
frame. However, most of the vital information was obtained during the stipulated data
collection period.
9. Conclusions
The current study assessed the global literature regarding COVID-19 and disasters
scientifically using Kantamaneni’s [20] methodology. Accordingly, the present study criti-
cally synthesises the data from diverse countries to effectively understand the strategies
and methods used to manage pandemics. Results and discussion identified that multi-
stakeholder participation is one of the most effective solutions to combat the COVID-19
pandemic and its impact on livelihood in the current situations. Moreover, results also
explored that the amalgamation of Multi-Stakeholder and Spatial Decision Support System
(MS-SDSS) has proven to be the most applicable model to identify the potential pan-
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demic sources and to control the spread of it across the world. While transdisciplinary
approaches to problem structuring and decision-making to combat COVID-19 seem ex-
tremely promising, the conceptual MS-SDSS can bring out a synergic relationship between
multi-stakeholders and help inform decision making in crisis management. This paper also
promotes the need to strengthen public health surveillance and preparedness for pandemic
management, through research, capacity building and action. The review study suggests
that governments partner with collaborating institutions and provide support in surveil-
lance, preparedness and capacity building during public health emergencies. The study
also encourages an inclusive, innovative community-based approach, (including virtual
and home-based care). Cumulatively, the current study results help the researchers, diverse
stakeholders, policy and decision-makers to continue further research or work on this topic.
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